AC Immune (ACIU) Shares Outstanding (2014 - 2026)
AC Immune (ACIU) posted quarterly Shares Outstanding (Entity) of $101.7 million for Q4 2025, up 1.33% year-over-year from $100.4 million in Q4 2024, and up 0.84% quarter-over-quarter from $100.9 million in Q3 2025.
AC Immune (ACIU) Shares Outstanding (2014 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Shares Outstanding (Entity) for 12 consecutive years, with $101.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 1.33% year-over-year to $101.7 million; the TTM figure through Dec 2025 stood at $101.7 million (up 1.33% YoY), while the FY2025 annual figure was $101.7 million, up 1.33% from the prior year.
- Shares Outstanding (Entity) improved to $101.7 million in Q4 2025 per ACIU's latest filing, from $100.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $101.7 million in Q4 2025 and bottomed at $72.3 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $89.5 million across 5 years, with a median of $84.7 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 0.17% — and 2023, when it grew 18.63%.
- AC Immune's Shares Outstanding (Entity) stood at $83.5 million in 2021, then gained by 0.17% to $83.6 million in 2022, then climbed by 18.63% to $99.2 million in 2023, then increased by 1.22% to $100.4 million in 2024, then advanced by 1.33% to $101.7 million in 2025.
- Business Quant data shows ACIU's Shares Outstanding (Entity) at $101.7 million in Q4 2025, $100.9 million in Q3 2025, and $100.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 101.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.96 Mn |
| Mar 31, 2026 | 100.75 Mn |
| Dec 31, 2025 | 100.75 Mn |
| Sep 30, 2025 | 100.89 Mn |
| Jun 30, 2025 | 100.63 Mn |
| Mar 31, 2025 | 99.69 Mn |
| Dec 31, 2024 | 99.69 Mn |
| Sep 30, 2024 | 99.84 Mn |
| Jun 30, 2024 | 99.55 Mn |
| Mar 31, 2024 | 84.69 Mn |
| Dec 31, 2023 | 84.69 Mn |
| Sep 30, 2023 | 84.72 Mn |
| Jun 30, 2023 | 84.61 Mn |
| Mar 31, 2023 | 83.55 Mn |
| Dec 31, 2022 | 83.55 Mn |
| Sep 30, 2022 | 83.59 Mn |
| Jun 30, 2022 | 84.46 Mn |
| Mar 31, 2022 | 83.49 Mn |
| Dec 31, 2021 | 74.95 Mn |
| Sep 30, 2021 | 72.89 Mn |